Clinical Trials Browser

Terminated × Burkitt Lymphoma × blinatumomab × Clear all

NCT04556084 2025-05-13

Blinatumomab Bridging Therapy for BALL

Phase 2 Terminated

2 enrolled 11 charts

Burkitt Lymphoma

NCT03518112 2022-11-04

Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 2 Terminated

6 enrolled 10 charts

Burkitt Lymphoma